BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25149358)

  • 21. The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence.
    Haferkamp S; Tran SL; Becker TM; Scurr LL; Kefford RF; Rizos H
    Aging (Albany NY); 2009 May; 1(6):542-56. PubMed ID: 20157537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Regulation of Cellular Functions by the p53 Protein: Cellular Senescence.
    Tonnessen-Murray CA; Lozano G; Jackson JG
    Cold Spring Harb Perspect Med; 2017 Feb; 7(2):. PubMed ID: 27881444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CSN5 specifically interacts with CDK2 and controls senescence in a cytoplasmic cyclin E-mediated manner.
    Yoshida A; Yoneda-Kato N; Kato JY
    Sci Rep; 2013; 3():1054. PubMed ID: 23316279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new p53 target gene, RKIP, is essential for DNA damage-induced cellular senescence and suppression of ERK activation.
    Lee SJ; Lee SH; Yoon MH; Park BJ
    Neoplasia; 2013 Jul; 15(7):727-37. PubMed ID: 23814485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct roles for p107 and p130 in Rb-independent cellular senescence.
    Lehmann BD; Brooks AM; Paine MS; Chappell WH; McCubrey JA; Terrian DM
    Cell Cycle; 2008 May; 7(9):1262-8. PubMed ID: 18418057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDK4 inhibition restores G(1)-S arrest in MYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage.
    Gogolin S; Ehemann V; Becker G; Brueckner LM; Dreidax D; Bannert S; Nolte I; Savelyeva L; Bell E; Westermann F
    Cell Cycle; 2013 Apr; 12(7):1091-104. PubMed ID: 23462184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preterm labor in the absence of acute histologic chorioamnionitis is characterized by cellular senescence of the chorioamniotic membranes.
    Gomez-Lopez N; Romero R; Plazyo O; Schwenkel G; Garcia-Flores V; Unkel R; Xu Y; Leng Y; Hassan SS; Panaitescu B; Cha J; Dey SK
    Am J Obstet Gynecol; 2017 Nov; 217(5):592.e1-592.e17. PubMed ID: 28847437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors.
    Dietrich C; Trub A; Ahn A; Taylor M; Ambani K; Chan KT; Lu KH; Mahendra CA; Blyth C; Coulson R; Ramm S; Watt AC; Matsa SK; Bisi J; Strum J; Roberts P; Goel S
    Cancer Discov; 2024 Mar; 14(3):446-467. PubMed ID: 38047585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel ARF/p53-independent senescence pathways in cancer repression.
    Chan CH; Gao Y; Moten A; Lin HK
    J Mol Med (Berl); 2011 Sep; 89(9):857-67. PubMed ID: 21594579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of wild-type p53-induced phosphatase 1 (Wip1) plays a critical role in regulating several p53-dependent functions in premature senescent tumor cells.
    Crescenzi E; Raia Z; Pacifico F; Mellone S; Moscato F; Palumbo G; Leonardi A
    J Biol Chem; 2013 Jun; 288(23):16212-16224. PubMed ID: 23612976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing SUMO2 promotes protection against degradation and apoptosis of nucleus pulposus cells through p53 signaling pathway in intervertebral disc degeneration.
    Jin LZ; Lu JS; Gao JW
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29700214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Senescence and aging: the critical roles of p53.
    Rufini A; Tucci P; Celardo I; Melino G
    Oncogene; 2013 Oct; 32(43):5129-43. PubMed ID: 23416979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
    Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
    Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogene-induced senescence pathways weave an intricate tapestry.
    Yaswen P; Campisi J
    Cell; 2007 Jan; 128(2):233-4. PubMed ID: 17254959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 Promotes cell survival due to the reversibility of its cell-cycle checkpoints.
    Lukin DJ; Carvajal LA; Liu WJ; Resnick-Silverman L; Manfredi JJ
    Mol Cancer Res; 2015 Jan; 13(1):16-28. PubMed ID: 25158956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular senescence and tumor suppressor gene p16.
    Rayess H; Wang MB; Srivatsan ES
    Int J Cancer; 2012 Apr; 130(8):1715-25. PubMed ID: 22025288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras.
    Tremain R; Marko M; Kinnimulki V; Ueno H; Bottinger E; Glick A
    Oncogene; 2000 Mar; 19(13):1698-709. PubMed ID: 10763827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. YPEL3, a p53-regulated gene that induces cellular senescence.
    Kelley KD; Miller KR; Todd A; Kelley AR; Tuttle R; Berberich SJ
    Cancer Res; 2010 May; 70(9):3566-75. PubMed ID: 20388804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA repair factor RAD18 and DNA polymerase Polκ confer tolerance of oncogenic DNA replication stress.
    Yang Y; Gao Y; Mutter-Rottmayer L; Zlatanou A; Durando M; Ding W; Wyatt D; Ramsden D; Tanoue Y; Tateishi S; Vaziri C
    J Cell Biol; 2017 Oct; 216(10):3097-3115. PubMed ID: 28835467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.